Objectif THERACAT is an international and multidisciplinary consortium aiming at the training of 13 ESRs on the innovative topic of novel bio-orthogonal catalysis-based tools for cancer therapy. This ETN comprises 6 academic partners, 3 industrial partners active in the pharmaceutical market (1 large pharmaceutical company, Teva, and 2 SMEs, BiogelX and Tagworks) and 3 partners with focus on science communication (Cancer research UK), gender and minorities (UAB-Observatory for Equality) and management and entrepreneurship (ESADE business school). The combination of academic, private and society-involved organisations will provide a broad training for the 13 ESRs recruited, equipping them with the necessary skills to succeed as scientists, industrial researchers and entrepreneurs. The development of novel cancer therapies is a major challenge for academic research and pharmaceutical industries. THERACAT aims to establish a training programme focused on the development of THERApeutic CATalysts. In this strategy, materials bearing a catalytic unit are delivered to the tumour and subsequently non-active prodrugs are administered. The prodrugs are non-toxic and therefore generate limited side effects. Only at the tumour site the catalytic particles convert the prodrugs into active compounds that generate a therapeutic effect. This approach presents several advantages on the classical drug delivery paradigm including limited side effects and prolonged efficacy. This multidisciplinary research programme will be the setting for the training of 13 ESRs. The combination of the research expertise, the cutting-edge facilities and the complementary skills present in the consortium holds a great promise for the advancement of their careers, as well as of the knowledge of catalysis-based anticancer therapies and the development of marketable technologies and products. Champ scientifique social scienceseconomics and businessbusiness and managemententrepreneurshipmedical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsmedical and health sciencesclinical medicineoncologynatural scienceschemical sciencescatalysis Mots‑clés Bio-orthogonal catalysis nanomedicine catalysis in living cells Chemical Biology Programme(s) H2020-EU.1.3. - EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions Main Programme H2020-EU.1.3.1. - Fostering new skills by means of excellent initial training of researchers Thème(s) MSCA-ITN-2017 - Innovative Training Networks Appel à propositions H2020-MSCA-ITN-2017 Voir d’autres projets de cet appel Régime de financement MSCA-ITN - Marie Skłodowska-Curie Innovative Training Networks (ITN) Coordinateur FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA Contribution nette de l'UE € 271 765,16 Adresse CARRER BALDIRI REIXAC PLANTA 2A 10-12 08028 Barcelona Espagne Voir sur la carte Région Este Cataluña Barcelona Type d’activité Research Organisations Liens Contacter l’organisation Opens in new window Site web Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total € 271 765,16 Participants (8) Trier par ordre alphabétique Trier par contribution nette de l'UE Tout développer Tout réduire TECHNISCHE UNIVERSITEIT EINDHOVEN Pays-Bas Contribution nette de l'UE € 758 603,49 Adresse GROENE LOPER 3 5612 AE Eindhoven Voir sur la carte Région Zuid-Nederland Noord-Brabant Zuidoost-Noord-Brabant Type d’activité Higher or Secondary Education Establishments Liens Contacter l’organisation Opens in new window Site web Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total € 758 603,49 RIJKSUNIVERSITEIT GRONINGEN Pays-Bas Contribution nette de l'UE € 255 374,28 Adresse Broerstraat 5 9712CP Groningen Voir sur la carte Région Noord-Nederland Groningen Overig Groningen Type d’activité Higher or Secondary Education Establishments Liens Contacter l’organisation Opens in new window Site web Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total € 255 374,28 UNIVERSITAT BASEL Suisse Contribution nette de l'UE € 265 226,76 Adresse PETERSPLATZ 1 4051 Basel Voir sur la carte Région Schweiz/Suisse/Svizzera Nordwestschweiz Basel-Stadt Type d’activité Higher or Secondary Education Establishments Liens Contacter l’organisation Opens in new window Site web Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total € 265 226,76 THE UNIVERSITY OF EDINBURGH Royaume-Uni Contribution nette de l'UE € 546 575,76 Adresse OLD COLLEGE, SOUTH BRIDGE EH8 9YL Edinburgh Voir sur la carte Région Scotland Eastern Scotland Edinburgh Type d’activité Higher or Secondary Education Establishments Liens Contacter l’organisation Opens in new window Site web Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total € 546 575,76 TEL AVIV UNIVERSITY Israël Contribution nette de l'UE € 520 601,04 Adresse RAMAT AVIV 69978 Tel Aviv Voir sur la carte Type d’activité Higher or Secondary Education Establishments Liens Contacter l’organisation Opens in new window Site web Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total € 520 601,04 TEVA PHARMACEUTICAL INDUSTRIES LIMITED Israël Contribution nette de l'UE € 260 300,52 Adresse 5 BASEL ST 49131 Petach Tivka Voir sur la carte Type d’activité Private for-profit entities (excluding Higher or Secondary Education Establishments) Liens Contacter l’organisation Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total € 260 300,52 TAGWORKS PHARMACEUTICALS BV Pays-Bas Contribution nette de l'UE € 255 374,28 Adresse TOERNOOIVELD 1 6525 ED Nijmegen Voir sur la carte PME L’entreprise s’est définie comme une PME (petite et moyenne entreprise) au moment de la signature de la convention de subvention. Oui Région Oost-Nederland Gelderland Arnhem/Nijmegen Type d’activité Private for-profit entities (excluding Higher or Secondary Education Establishments) Liens Contacter l’organisation Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total € 255 374,28 BIOGELX LIMITED Participation terminée Royaume-Uni Contribution nette de l'UE € 246 945,96 Adresse BIOCITY SCOTLAND BO'NESS ROAD LANARKSHIRE ML1 5UH NEWHOUSE Voir sur la carte PME L’entreprise s’est définie comme une PME (petite et moyenne entreprise) au moment de la signature de la convention de subvention. Oui Région Scotland West Central Scotland North Lanarkshire Type d’activité Private for-profit entities (excluding Higher or Secondary Education Establishments) Liens Contacter l’organisation Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total € 246 945,96
